| Year |
Citation |
Score |
| 2020 |
Parikh N, Keshishian E, Sharma A, Roca M, Manley B, Poch M, Grass GD, Torres-Roca J, Boulware D, Johnstone P, Montejo M, Smith J, Pow-Sang J, Yamoah K. Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis. Advances in Radiation Oncology. 5: 905-909. PMID 33083652 DOI: 10.1016/J.Adro.2020.03.015 |
0.32 |
|
| 2020 |
Mahal BA, Alshalalfa M, Kensler KH, Chowdhury-Paulino I, Kantoff P, Mucci LA, Schaeffer EM, Spratt D, Yamoah K, Nguyen PL, Rebbeck TR. Racial Differences in Genomic Profiling of Prostate Cancer. The New England Journal of Medicine. 383: 1083-1085. PMID 32905685 DOI: 10.1056/Nejmc2000069 |
0.343 |
|
| 2020 |
Yuan Z, Fernandez D, Dhillon J, Abraham-Miranda J, Awasthi S, Kim Y, Zhang J, Jain R, Serna A, Pow-Sang JM, Poch M, Li R, Manley B, Fink A, Naghavi A, ... ... Yamoah K, et al. Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis. Prostate Cancer and Prostatic Diseases. PMID 32651467 DOI: 10.1038/S41391-020-0254-Y |
0.314 |
|
| 2020 |
Darst BF, Wan P, Sheng X, Bensen JT, Ingles SA, Rybicki BA, Nemesure B, John EM, Fowke JH, Stevens VL, Berndt SI, Huff CD, Strom SS, Park JY, Zheng W, ... ... Yamoah K, et al. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. European Urology. PMID 32409115 DOI: 10.1016/J.Eururo.2020.04.060 |
0.308 |
|
| 2020 |
Tosoian JJ, Birer SR, Jeffrey Karnes R, Zhang J, Davicioni E, Klein EE, Freedland SJ, Weinmann S, Trock BJ, Dess RT, Zhao SG, Jackson WC, Yamoah K, Pra AD, Mahal BA, et al. Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier. Prostate Cancer and Prostatic Diseases. PMID 32231245 DOI: 10.1038/S41391-020-0226-2 |
0.341 |
|
| 2020 |
Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Fu P, Yamoah K, Khani F, Robinson BD, Rebbeck TR, Feldman M, Lal P, Madabhushi A. Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32139401 DOI: 10.1158/1078-0432.Ccr-19-2659 |
0.363 |
|
| 2020 |
Yamoah K, Awasthi S, Mahal B, Zhao SG, Abraham-Miranda J, Gerke TA, Davicioni E, Rounbehler RJ, Berglund AE, Grass DG, Park JY, Pow-Sang JM, Fernandez D, Jain RK, Schaeffer EM, et al. Abstract 3520: Immunogenomic landscape of grade group 5 prostate cancer predicts risk of lethal outcomes and may inform treatment response Epidemiology. 80: 3520-3520. DOI: 10.1158/1538-7445.Am2020-3520 |
0.36 |
|
| 2020 |
Kensler KH, Alshalalfa M, Mahal BA, Liu Y, Davicioni E, Awasthi S, Yamoah K, Rebbeck TR. Abstract 3509: Racial variation in molecularly-defined prostate cancer subtypes Epidemiology. 80: 3509-3509. DOI: 10.1158/1538-7445.Am2020-3509 |
0.344 |
|
| 2019 |
Howard LE, Zhang J, Fishbane N, Hoedt AM, Klaassen Z, Spratt DE, Vidal AC, Lin D, Hitchins MP, You S, Freeman MR, Yamoah K, Davicioni E, Freedland SJ. Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting. Prostate Cancer and Prostatic Diseases. PMID 31844180 DOI: 10.1038/S41391-019-0197-3 |
0.309 |
|
| 2019 |
Creed JH, Berglund AE, Rounbehler RJ, Awasthi S, Cleveland JL, Park JY, Yamoah K, Gerke TA. Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31757784 DOI: 10.1158/1055-9965.Epi-19-0407 |
0.352 |
|
| 2019 |
Gerke T, Awasthi S, Yamoah K. Biology vs Access to Care-Relative Contribution to Racial Disparities in Prostate Cancer. Jama Oncology. PMID 31670755 DOI: 10.1001/Jamaoncol.2019.4497 |
0.326 |
|
| 2019 |
Asamoah FA, Yarney J, Awasthi S, Vanderpuye V, Dadzie MA, Fink A, Naghavi AO, Abrahams A, Mensah JE, Sasu E, Tagoe SN, Dhillon J, Johnstone PAS, Yamoah K. Definitive Radiation Treatment Patterns and Outcomes for Low and Intermediate Risk Prostate Cancer Patients: A Cross-Continental Comparative Study. American Journal of Clinical Oncology. PMID 31584456 DOI: 10.1097/Coc.0000000000000589 |
0.345 |
|
| 2019 |
Echevarria MI, Awasthi S, Cheng CH, Berglund AE, Rounbehler RJ, Gerke TA, Takhar M, Davicioni E, Klein EA, Freedland SJ, Ross AE, Schaeffer EM, Den RB, Cleveland JL, Park JY, ... ... Yamoah K, et al. African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome. The Journal of Urology. 101097JU000000000000. PMID 31107158 DOI: 10.1097/Ju.0000000000000193 |
0.339 |
|
| 2019 |
Awasthi S, Gerke T, Williams VL, Asamoah F, Fink AK, Balkrishnan R, Park JY, Yamoah K. Interrelationship Between Health Insurance Status and Prostate Cancer Grade Can Have Critical Impact on Prostate Cancer Disease Control: A Retrospective Cohort Study. Cancer Control : Journal of the Moffitt Cancer Center. 26: 1073274819837184. PMID 30935222 DOI: 10.1177/1073274819837184 |
0.316 |
|
| 2019 |
Studenski M, Gardner S, Yamoah K, Buzurovic I, Showalter T, Den R. SU-E-T-166: Use of an in Vivo Dosimeter to Assess the Implications of Daily Prostate Rotations. Medical Physics. 39: 3741. PMID 28517846 DOI: 10.1118/1.4735224 |
0.322 |
|
| 2019 |
Leo P, Janowczyk A, Elliott R, Janaki N, Shiradkar R, Farrè X, Yamoah K, Rebbeck T, Shih N, Khani F, Robinson BD, Eklund L, Ettala O, Taimen P, Bostrom P, et al. Computerized histomorphometric features of glandular architecture predict risk of biochemical recurrence following radical prostatectomy: A multisite study. Journal of Clinical Oncology. 37: 5060-5060. DOI: 10.1200/Jco.2019.37.15_Suppl.5060 |
0.303 |
|
| 2019 |
Damonte J, Roy S, Benson C, Jamison K, Park H, Pollack A, Masood S, Yeo C, Kim Y, Dhillon J, Yamoah K, Pow-Sang J, Sellers TA, Gwede CK, Park JY. Abstract 4183: Recruiting African-American prostate cancer patients for biobank research Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-4183 |
0.335 |
|
| 2019 |
Creed JH, Berglund AE, Rounbehler RJ, Awasthi S, Cleveland JL, Park JY, Yamoah K, Gerke TA. Abstract 4471: Commercial gene expression tests for prostate cancer prognosis provide paradoxical estimates of race-specific risk Cancer Research. 79: 4471-4471. DOI: 10.1158/1538-7445.Am2019-4471 |
0.338 |
|
| 2019 |
Yamoah K, Awasthi S, Lal P, Naghavi AO, Mahajan S, Park JY, Rounbehler R, Gerke T, Berglund A, PowSang J, Dhillon J, Rebbeck TR. Abstract 1568: Clinical implications of tmprss2-erg fusion and tumor location in prostate cancer Cancer Research. 79: 1568-1568. DOI: 10.1158/1538-7445.Am2019-1568 |
0.334 |
|
| 2018 |
Awasthi S, Gerke T, Park JY, Asamoah FA, Williams VL, Fink AK, Balkrishnan R, Lee DI, Malkowicz SB, Lal P, Dhillon J, Pow-Sang JM, Rebbeck TR, Yamoah K. Optimizing Time-to-Treatment to achieve durable biochemical disease control after surgery in prostate cancer - A multi-institutional cohort study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30413401 DOI: 10.1158/1055-9965.Epi-18-0812 |
0.342 |
|
| 2018 |
Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, et al. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. The Lancet. Oncology. PMID 30316827 DOI: 10.1016/S1470-2045(18)30528-X |
0.327 |
|
| 2018 |
Rounbehler RJ, Berglund AE, Gerke T, Takhar MM, Awasthi S, Li W, Davicioni E, Erho NG, Ross AE, Schaeffer EM, Klein EA, Karnes RJ, Jenkins RB, Cleveland JL, Park JY, ... Yamoah K, et al. Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30108099 DOI: 10.1158/1055-9965.Epi-18-0369 |
0.353 |
|
| 2018 |
Asamoah FA, Yarney J, Awasthi S, Vanderpuye V, Venkat PS, Fink AK, Naghavi AO, Abrahams A, Mensah JE, Sasu E, Tagoe SNA, Johnstone PAS, Yamoah K. Contemporary Radiation Treatment of Prostate Cancer in Africa: A Ghanaian Experience. Journal of Global Oncology. 1-13. PMID 30085846 DOI: 10.1200/Jgo.17.00234 |
0.336 |
|
| 2018 |
Williams VL, Awasthi S, Fink AK, Pow-Sang JM, Park JY, Gerke T, Yamoah K. African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015. Cancer Medicine. PMID 29601662 DOI: 10.1002/Cam4.1451 |
0.337 |
|
| 2018 |
Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Yamoah K, Rebbeck T, Feldman MD, Lal P, Madabhushi A. Computer-extracted stromal features of African-Americans versus Caucasians from H&E slides and impact on prognosis of biochemical recurrence. Journal of Clinical Oncology. 36: 12075-12075. DOI: 10.1200/Jco.2018.36.15_Suppl.12075 |
0.324 |
|
| 2018 |
Echevarria M, Awasthi S, Cheng C, Berglund A, Rounbehler R, Gerke T, Takhar M, Davicioni E, Erho N, Klein E, Freedland S, Ross A, Schaeffer E, Den R, Cleveland J, ... ... Yamoah K, et al. Novel Genomic Biomarker Panel Predictive of Aggressive Disease in African American Men with Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e108. DOI: 10.1016/J.Ijrobp.2018.07.399 |
0.331 |
|
| 2017 |
Echevarria MI, Naghavi AO, Abuodeh YA, Ahmed KA, Chevere C, Fernandez D, Yamoah K. Low-dose-rate Brachytherapy for Prostate Cancer in Low-resource Settings. International Journal of Radiation Oncology, Biology, Physics. 99: 378-382. PMID 28871987 DOI: 10.1016/J.Ijrobp.2017.04.002 |
0.323 |
|
| 2017 |
Luu HN, Lin HY, Sørensen KD, Ogunwobi OO, Kumar N, Chornokur G, Phelan C, Jones D, Kidd L, Batra J, Yamoah K, Berglund A, Rounbehler RJ, Yang M, Lee SH, et al. miRNAs associated with prostate cancer risk and progression. Bmc Urology. 17: 18. PMID 28320379 DOI: 10.1186/S12894-017-0206-6 |
0.34 |
|
| 2017 |
Kim H, Kalchman I, Santiago-Jiménez M, Lehrer J, Guo J, Hermann G, Yamoah K, Alshalalfa M, Huang HC, Ross AE, Schaeffer EM, Davicioni E, Erho N, Yousefi K, Den RB. Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes. Cancer. PMID 28140459 DOI: 10.1002/Cncr.30580 |
0.32 |
|
| 2017 |
Kilinski K, Naghavi A, Abuodeh YA, Echevarria M, Yamoah K. The impact of pretreatment MRI on genitourinary and gastrointestinal toxicity after radiation therapy in patients with localized prostate cancer. Journal of Clinical Oncology. 35: 119-119. DOI: 10.1200/Jco.2017.35.6_Suppl.119 |
0.319 |
|
| 2017 |
Yuan Z, Yang G, Oliver D, Takhar M, Erho N, Berglund A, Park J, Rounbehler R, Gerke T, Jordan J, Davicioni E, Torres-Roca J, Mulé J, Rayford W, Yamoah K. Integrative Characterization of the 12-Chemokine Gene Expression Signature in Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E279. DOI: 10.1016/J.Ijrobp.2017.06.1270 |
0.327 |
|
| 2017 |
Yamoah K, Rounbehler R, Takhar M, Gerke T, Park J, Awasthi S, Erho N, Davicioni E, Cleveland J, Berglund A. Distinct AR-Dependent Transcriptional Program in TMPRSS2-ERG Fusion Negative Tumors in African-American Men With Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E276. DOI: 10.1016/J.Ijrobp.2017.06.1262 |
0.333 |
|
| 2017 |
Echevarria M, Naghavi A, Abuodeh Y, Kilinski K, Pow-Sang J, Johnstone P, Fernandez D, Parikh N, Gage K, Yamoah K. MRI Heterogeneity in Prostate Cancer Predicts for Aggressive Pathology International Journal of Radiation Oncology*Biology*Physics. 99: E229. DOI: 10.1016/J.Ijrobp.2017.06.1151 |
0.338 |
|
| 2016 |
Echevarria MI, Naghavi AO, Venkat PS, Abuodeh YA, Chevere C, Yamoah K. The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy. Journal of Contemporary Brachytherapy. 8: 386-390. PMID 27895679 DOI: 10.5114/Jcb.2016.63357 |
0.304 |
|
| 2016 |
Yamoah K, Johnstone PA. Proton beam therapy: clinical utility and current status in prostate cancer. Oncotargets and Therapy. 9: 5721-5727. PMID 27695349 DOI: 10.2147/Ott.S100518 |
0.329 |
|
| 2016 |
Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. Bmc Cancer. 16: 557. PMID 27473687 DOI: 10.1186/S12885-016-2572-Y |
0.338 |
|
| 2015 |
Yamoah K, Showalter TN, Ohri N. Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials. International Journal of Radiation Oncology, Biology, Physics. 93: 737-45. PMID 26530740 DOI: 10.1016/J.Ijrobp.2015.07.2284 |
0.3 |
|
| 2015 |
Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den R, Lal P, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, et al. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26195723 DOI: 10.1200/Jco.2014.59.8912 |
0.35 |
|
| 2015 |
Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urologic Oncology. 33: 70.e15-22. PMID 25304288 DOI: 10.1016/J.Urolonc.2014.07.005 |
0.358 |
|
| 2015 |
Lal P, Yamoah K, Ziober A, Walker A, Zhou W, Spangler E, Zeigler-Johnson C, Feldman M, Rebbeck TR. Abstract 4608: Racial differences in the distribution of prostate tumor biomarkers and treatment failure: The SCORE study Cancer Research. 75: 4608-4608. DOI: 10.1158/1538-7445.Am2015-4608 |
0.352 |
|
| 2015 |
Yamoah K, Johnson M, Choeurng V, Yousefi K, Haddad Z, Den R, Lal P, Feldman M, Dicker A, Klein E, Davicioni E, Rebbeck T, Schaeffer E. MP6-03 A NOVEL BIOMARKER SIGNATURE WHICH MAY PREDICT AGGRESSIVE DISEASE IN AFRICAN-AMERICAN MEN WITH PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.250 |
0.342 |
|
| 2014 |
Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 13: 456-64. PMID 24953945 DOI: 10.1016/J.Brachy.2014.04.003 |
0.326 |
|
| 2014 |
Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. Future Oncology (London, England). 10: 457-74. PMID 24559451 DOI: 10.2217/Fon.13.196 |
0.36 |
|
| 2014 |
Zaorsky NG, Doyle LA, Yamoah K, Andrel JA, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB. High dose rate brachytherapy boost for prostate cancer: a systematic review. Cancer Treatment Reviews. 40: 414-25. PMID 24231548 DOI: 10.1016/J.Ctrv.2013.10.006 |
0.302 |
|
| 2013 |
Gardner S, Zaorsky N, Yamoah K, Cui Y, Xiao Y, Den R, Studenski M. SU-E-T-598: Variability of Computer-Generated Organ at Risk Contours as Part of An Automated Deformable Registration Workflow for Prostate Cancer. Medical Physics. 40: 343. PMID 28519122 DOI: 10.1118/1.4815026 |
0.319 |
|
| 2013 |
Gardner S, Studenski M, Zaorsky N, Yamoah K, Cui Y, Xiao Y, Den R. Cone Beam Computed Tomography Contouring Variability on Derivative Contours Generated With an Automated Deformable Registration Workflow for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 87: S147. DOI: 10.1016/J.Ijrobp.2013.06.380 |
0.302 |
|
| 2011 |
Yamoah K, Stone N, Stock R. Impact of race on biochemical disease recurrence after prostate brachytherapy. Cancer. 117: 5589-600. PMID 21692058 DOI: 10.1002/Cncr.26183 |
0.343 |
|
| 2008 |
Fang L, Wang X, Yamoah K, Chen PL, Pan ZQ, Huang L. Characterization of the human COP9 signalosome complex using affinity purification and mass spectrometry. Journal of Proteome Research. 7: 4914-25. PMID 18850735 DOI: 10.1021/Pr800574C |
0.543 |
|
| 2008 |
Yamoah K, Oashi T, Sarikas A, Gazdoiu S, Osman R, Pan ZQ. Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tail. Proceedings of the National Academy of Sciences of the United States of America. 105: 12230-5. PMID 18723677 DOI: 10.1073/Pnas.0806155105 |
0.71 |
|
| 2007 |
Kumar A, Wu H, Collier-Hyams LS, Hansen JM, Li T, Yamoah K, Pan ZQ, Jones DP, Neish AS. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. The Embo Journal. 26: 4457-66. PMID 17914462 DOI: 10.1038/Sj.Emboj.7601867 |
0.531 |
|
| 2007 |
Gazdoiu S, Yamoah K, Wu K, Pan ZQ. Human Cdc34 employs distinct sites to coordinate attachment of ubiquitin to a substrate and assembly of polyubiquitin chains. Molecular and Cellular Biology. 27: 7041-52. PMID 17698585 DOI: 10.1128/Mcb.00812-07 |
0.711 |
|
| 2005 |
Yamoah K, Wu K, Pan ZQ. In vitro cleavage of Nedd8 from cullin 1 by COP9 signalosome and deneddylase 1. Methods in Enzymology. 398: 509-22. PMID 16275355 DOI: 10.1016/S0076-6879(05)98042-7 |
0.58 |
|
| 2005 |
Gazdoiu S, Yamoah K, Wu K, Escalante CR, Tappin I, Bermudez V, Aggarwal AK, Hurwitz J, Pan ZQ. Proximity-induced activation of human Cdc34 through heterologous dimerization. Proceedings of the National Academy of Sciences of the United States of America. 102: 15053-8. PMID 16210246 DOI: 10.1073/Pnas.0507646102 |
0.713 |
|
| 2004 |
Pan ZQ, Kentsis A, Dias DC, Yamoah K, Wu K. Nedd8 on cullin: Building an expressway to protein destruction Oncogene. 23: 1985-1997. PMID 15021886 DOI: 10.1038/Sj.Onc.1207414 |
0.739 |
|
| 2003 |
Wu K, Yamoah K, Dolios G, Gan-Erdene T, Tan P, Chen A, Lee CG, Wei N, Wilkinson KD, Wang R, Pan ZQ. DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1. The Journal of Biological Chemistry. 278: 28882-91. PMID 12759363 DOI: 10.1074/Jbc.M302888200 |
0.678 |
|
| Show low-probability matches. |